Abstract
Glucagon-like-peptide-1 (GLP-1) is strongly insulinotropic in patients with Type II (non-insulin-dependent) diabetes mellitus, whereas glucose-dependent insulinotropic polypeptide (GIP) is less effective. Our investigation evaluated "early" (protocol 1) - and "late phase" (protocol 2) insulin and C-peptide responses to GLP-1 and GIP stimulation in patients with Type II diabetes.
Originalsprog | Engelsk |
---|---|
Tidsskrift | Diabetologia |
Vol/bind | 45 |
Udgave nummer | 8 |
Sider (fra-til) | 1111-9 |
Antal sider | 9 |
ISSN | 0012-186X |
DOI | |
Status | Udgivet - 1 aug. 2002 |